Myasthenia Gravis and Related Disorders

  • Henry J. Kaminski
  • Linda L. Kusner

Part of the Current Clinical Neurology book series (CCNEU)

Table of contents

  1. Front Matter
    Pages i-xiii
  2. Jie Luo, Jon M. Lindstrom
    Pages 13-45
  3. Rozen Le Panse, Sonia Berrih-Aknin
    Pages 47-60
  4. Linda L. Kusner, Rozen Le Panse, Mario Losen, William D. Phillips
    Pages 61-70
  5. Melissa Nel, Jeannine M. Heckmann
    Pages 71-84
  6. Jan B. M. Kuks
    Pages 85-100
  7. Sui Hsien Wong, Michael Benatar
    Pages 101-112
  8. Alexander Marx, Philipp Ströbel, Cleo-Aron Weis
    Pages 113-129
  9. Christopher David Geiger, Bashar Katirji
    Pages 131-152
  10. Henry J. Kaminski
    Pages 169-187
  11. Jose Americo M. Fernandes, Jose I. Suarez
    Pages 189-197
  12. Joshua R. Sonett, Bianca Bromberger, Alfred Jaretzki III
    Pages 199-219
  13. C. Michel Harper, Vanda A. Lennon
    Pages 221-237
  14. Hakan Cetin, Angela Vincent
    Pages 239-250
  15. David Beeson
    Pages 251-274
  16. James F. Howard Jr.
    Pages 275-298
  17. Robert H. Paul, Paola García-Egan
    Pages 299-306
  18. Nicholas J. Silvestri, Gil I. Wolfe
    Pages 307-318
  19. Anna Rostedt Punga, Henry J. Kaminski, Jeffrey T. Guptill
    Pages 319-333
  20. Radwa Aly, Gary R. Cutter, Henry J. Kaminski
    Pages 335-344
  21. Back Matter
    Pages 345-353

About this book


The third edition of this important, gold-standard title outlines a range of significant advances in the study and understanding of myasthenia gravis. The overarching goal of this new edition is identical to the first and second -- to provide the clinician and the scientist with a common resource for understanding the profound achievements in the clinical, translational, and basic sciences of neuromuscular transmission disorders. In addition to several new authors and an extensive update of all chapters, this third edition includes summaries of pre-clinical research standards for autoimmune MG, along with a broad summary of MG clinical trial performance. The now greater understanding of the clinical presentation of MuSK-related MG and identification of potential new autoantigens, including LRP-4, is discussed. The development of treatment guidelines by groups in Japan, the United Kingdom, Germany, and an international consortium is also outlined. Myasthenia Gravis and Related Disorders, Third Edition, is an invaluable resource for meeting the many and varied needs of clinicians who treat patients with myasthenia gravis.


myasthenic syndromes toxic neuromuscular transmission disorders neuromuscular transmission neurology pulmonology

Editors and affiliations

  • Henry J. Kaminski
    • 1
  • Linda L. Kusner
    • 2
  1. 1.Department of NeurologyGeorge Washington UniversityWashington, DCUSA
  2. 2.Department of Pharmacology and PhysiologyGeorge Washington UniversityWashington, DCUSA

Bibliographic information

  • DOI
  • Copyright Information Springer International Publishing AG, part of Springer Nature 2018
  • Publisher Name Humana Press, Cham
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-3-319-73584-9
  • Online ISBN 978-3-319-73585-6
  • Buy this book on publisher's site